Racing on the Wrong Track

por Otvos, Laszlo
Publicado 2017

Potential Adiponectin Receptor Response Modifier Therapeutics

por Otvos, Laszlo
Publicado 2019

Current challenges in peptide-based drug discovery

por Otvos, Laszlo, Wade, John D.
Publicado 2014

Glioblastoma-derived Leptin Induces Tube Formation and Growth of Endothelial Cells: Comparison with VEGF Effects

por Ferla, Rita, Bonomi, Maria, Otvos, Laszlo, Surmacz, Eva
Publicado 2011

Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse

por Mozdzanowska, Krystyna, Zharikova, Darya, Cudic, Mare, Otvos, Laszlo, Gerhard, Walter
Publicado 2007

Exploring Leptin Antagonism in Ophthalmic Cell Models

por Scolaro, Laura, Parrino, Cristina, Coroniti, Roberta, Otvos, Laszlo, Surmacz, Eva
Publicado 2013

Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs

por Brakel, Alexandra, Volke, Daniela, Kraus, Carl N., Otvos, Laszlo, Hoffmann, Ralf
Publicado 2019

Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity

por Brakel, Alexandra, Kolano, Lisa, Kraus, Carl N., Otvos, Laszlo, Hoffmann, Ralf
Publicado 2022

Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models

por Coroniti, Roberta, Farjo, Rafal, Nuno, Didier J., Otvos, Laszlo, Scolaro, Laura, Surmacz, Eva
Publicado 2016

Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models

por Coroniti, Roberta, Farjo, Rafal, Nuno, Didier J., Otvos, Laszlo, Scolaro, Laura, Surmacz, Eva
Publicado 2016

Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity

por Brakel, Alexandra, Krizsan, Andor, Itzenga, Renke, Kraus, Carl N., Otvos, Laszlo, Hoffmann, Ralf
Publicado 2022

Complex Carbohydrates Are Not Removed During Processing of Glycoproteins by Dendritic Cells: Processing of Tumor Antigen MUC1 Glycopeptides for Presentation to Major Histocompatibi...

por Vlad, Anda M., Muller, Stefan, Cudic, Mare, Paulsen, Hans, Otvos, Laszlo, Hanisch, Franz-Georg, Finn, Olivera J.
Publicado 2002

Vaccination with M2e-Based Multiple Antigenic Peptides: Characterization of the B Cell Response and Protection Efficacy in Inbred and Outbred Mice

por Wolf, Amaya I., Mozdzanowska, Krystyna, Williams, Katie L., Singer, David, Richter, Monique, Hoffmann, Ralf, Caton, Andrew J., Otvos, Laszlo, Erikson, Jan
Publicado 2011

Leptin Receptor Blockade Attenuates Hypertension, but Does Not Affect Ventilatory Response to Hypoxia in a Model of Polygenic Obesity

por Kim, Lenise J., Shin, Mi-Kyung, Pho, Huy, Otvos, Laszlo, Tufik, Sergio, Andersen, Monica L., Pham, Luu V., Polotsky, Vsevolod Y.
Publicado 2021

The Effect of Selective D- or N(α)-Methyl Arginine Substitution on the Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20

por Li, Wenyi, Sun, Zhe, O'Brien-Simpson, Neil M., Otvos, Laszlo, Reynolds, Eric C., Hossain, Mohammed A., Separovic, Frances, Wade, John D.
Publicado 2017

Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Co...

por Bačík, Igor, Snyder, Heidi Link, Antón, Luis C., Russ, Gustav, Chen, Weisan, Bennink, Jack R., Urge, Laszlo, Otvos, Laszlo, Dudkowska, Boguslawa, Eisenlohr, Laurence, Yewdell, Jonathan W.
Publicado 1997

Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides—A Re...

por Fodor, András, Abate, Birhan Addisie, Deák, Péter, Fodor, László, Gyenge, Ervin, Klein, Michael G., Koncz, Zsuzsanna, Muvevi, Josephat, Ötvös, László, Székely, Gyöngyi, Vozik, Dávid, Makrai, László
Publicado 2020

Design and development of a peptide-based adiponectin receptor agonist for cancer treatment

por Otvos, Laszlo, Haspinger, Eva, La Russa, Francesca, Maspero, Federica, Graziano, Patrizia, Kovalszky, Ilona, Lovas, Sandor, Nama, Kaushik, Hoffmann, Ralf, Knappe, Daniel, Cassone, Marco, Wade, John, Surmacz, Eva
Publicado 2011

Development of second generation peptides modulating cellular adiponectin receptor responses

por Otvos, Laszlo, Knappe, Daniel, Hoffmann, Ralf, Kovalszky, Ilona, Olah, Julia, Hewitson, Tim D., Stawikowska, Roma, Stawikowski, Maciej, Cudic, Predrag, Lin, Feng, Wade, John D., Surmacz, Eva, Lovas, Sandor
Publicado 2014

Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target

por Marangoni, Roberta G., Masui, Yuri, Fang, Feng, Korman, Benjamin, Lord, Gabriel, Lee, Junghwa, Lakota, Katja, Wei, Jun, Scherer, Philipp E., Otvos, Laszlo, Yamauchi, Toshimasa, Kubota, Naoto, Kadowaki, Takashi, Asano, Yoshihide, Sato, Shinichi, Tourtellotte, Warren G., Varga, John
Publicado 2017